BPH GlobalASX:BP8 -25.00% Dividend Yield % is 0.00% as of Jul. 06, 2026. The stock has 6 warning signs investors should review. Among 518 Drug Manufacturers companies, BPH Global ranks worse than 193050% on this metric.
As of today (2026-07-06), the Trailing Annual Dividend Yield of BPH Global is 0.00%.
The historical rank and industry rank for BPH Global's Dividend Yield % or its related term are showing as below:
ASX:BP8's Dividend Yield % is not ranked *
in the Drug Manufacturers industry.
Industry Median: 1.92 * Ranked among companies with meaningful Dividend Yield % only.
The growth rate is calculated with least square regression.
For more information regarding to dividend, please check our Dividend Page.
* Please note that "special dividend" is not included in the calculation of dividend per share and related fields.
BPH Global (ASX:BP8) Dividend Yield % Explanation
Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.
Dividends may also qualify a lower tax rate for investors.
In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.
The historical data trend for BPH Global's Dividend Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, BPH Global's Dividend Yield %, along with its competitors' market caps and Dividend Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
BPH Global Dividend Yield % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, BPH Global's Dividend Yield % distribution charts can be found below:
* The bar in red indicates where BPH Global's Dividend Yield % falls into.
BPH Global (ASX:BP8) has a Dividend Yield % of 0.00% as of Jul. 06, 2026. Dividend yield is the ratio of company dividends to the share price. View historical data on BPH Global and its competitors. According to the industry distribution chart, BPH Global ranks #999999 out of 518 companies in the Drug Manufacturers industry.
Is BPH Global's Dividend Yield % too high?
BPH Global's current Dividend Yield % is 0.00%. Based on the distribution chart, BPH Global ranks #999999 out of 518 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers.
How does BPH Global's Dividend Yield % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, BPH Global ranks #999999 out of 518 companies for Dividend Yield %. This places BPH Global in the lower half of its industry. The industry median Dividend Yield % is 1.92. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Dividend Yield % for a Drug Manufacturers company?
The median Dividend Yield % among Drug Manufacturers companies is 1.92, based on 518 companies in the industry. Companies in the top quartile (top 25%) have a Dividend Yield % significantly above this median, while those in the bottom quartile fall well below. However, Dividend Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Dividend Yield % mean?
A high Dividend Yield % can signal that a stock is expensive relative to its fundamentals. Dividend yield is the ratio of company dividends to the share price. View historical data on BPH Global and its competitors. For the Drug Manufacturers industry, the median Dividend Yield % is 1.92 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. BPH Global's current Dividend Yield % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is BPH Global stock overvalued right now?
BPH Global (ASX:BP8) has a current Dividend Yield % of 0.00%. The current Dividend Yield % is 0.00%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Dividend Yield % calculated?
Dividend Yield % is calculated from a company's financial statements. For BPH Global (ASX:BP8), the current Dividend Yield % is 0.00% as of Jul. 06, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
BPH Global Ltd is a plant-focused biotechnology company with a focus on producing foods, health, and cosmetic products that deliver Traditional Chinese Medicine (TCM)-based health outcomes. It focuses on the research, development, production, and commercialization of TCM products, including bird's nest, seaweeds, and sea plants, which serve as sustainable plant-based protein sources and ingredients for food, nutrition, healthcare, cosmetics, and personal care industries. The company's geographical segment includes Australia, Indonesia, and China. The company's products comprise raw and processed bird's nest, sea grapes (Caulerpa lentillifera), and other seaweeds and sea plants.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASX:BP8 has been successfully added to your 